Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Auditor change
Employment agrmnt
Quarterly results
Appointed director
CC transcript
YIELD10 BIOSCIENCE, INC. (YTEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "Yield10 Bioscience Announces Second Quarter 2023 Financial Results -Harvesting underway for contracted winter and spring Camelina acres for the biofuels market"
08/11/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Placement Agency Agreement, by and among the Company, Maxim Group LLC, and Lake Street Capital Markets, LLC",
"Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering"
08/02/2023 8-K Quarterly results
05/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "YIELD10 BIOSCIENCE, INC. AMENDED AND RESTATED 2018 STOCK OPTION AND INCENTIVE PLAN"
05/19/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/04/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT YIELD10 BIOSCIENCE, INC. Warrant Shares: [ · ] Issue Date and Initial Exercise Date: [ · ], 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from YIELD10 BIOSCIENCE, INC., a Delaware corporation , up to [ · ] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and ...",
"FORM OF COMMON STOCK PURCHASE WARRANT YIELD10 BIOSCIENCE, INC. Warrant Shares: [ · ] Issue Date: [ · ], 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Issue Date and on or prior to 5:00 p.m. on the fifth anniversary of the Initial Exercise Date but not thereafter, to subscribe for and purchase from YIELD10 BIOSCIENCE, INC., a Delaware corporation , up to [ · ] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitali...",
"Yield10 Bioscience, Inc. 19 Presidential Way Woburn, Massachusetts 01801",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of May 3, 2023 between Yield10 Bioscience, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act as to the Shares and the Pre-Funded Warrants and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D thereunder as to the Private Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW,...",
"Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement"
05/03/2023 8-K Quarterly results
11/14/2022 8-K Quarterly results
10/05/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/26/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/09/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Yield10 Bioscience Announces Third Quarter 2021 Financial Results Management will Host a Conference Call Today at 4:30 p.m. to Review Financial Results and Provide a Corporate Update"
09/29/2021 8-K Quarterly results
08/11/2021 8-K Quarterly results
05/25/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
02/02/2021 8-K Quarterly results
01/19/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Yield10 Bioscience Announces Third Quarter 2020 Financial Results"
11/12/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Yield10 Bioscience Announces Collaboration with Rothamsted Research to Develop Advanced Technology for Producing Omega-3 Nutritional Oils in Camelina"
08/25/2020 8-K Quarterly results
08/11/2020 8-K Quarterly results
08/11/2020 8-K Quarterly results
06/09/2020 8-K Other Events
05/20/2020 8-K Submission of Matters to a Vote of Security Holders
05/14/2020 8-K Quarterly results
03/19/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results"
02/13/2020 8-K Quarterly results
01/31/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement"
01/15/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "CERTIFICATE OF AMENDMENT TO EFFECT REVERSE STOCK SPLIT",
"Yield10 Bioscience Announces 1-for-40 Reverse Stock Split"
01/09/2020 8-K Submission of Matters to a Vote of Security Holders
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy